BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:5th Pharma Pricing\, Reimbursement &amp\; Market Access 2021\n
 \n“Critical guide for successfully identifying your pricing\, reimburseme
 nt and market access strategies”\n\n28th - 29th September 2021\, Virtual 
 Conference (Time Zone - EST)\n\nThis conference will provide an overview 
 of global pricing\, market access systems and cost management techniques\
 , as well as in-depth discussion of some of the most current trends and c
 hanges. This Conference will bring together top pharmaceutical\, biotechn
 ology and regulatory representatives under one roof that will address the
  key issues of the industry. It will be studied with the help of case stu
 dies and industry experiences. Following a raft of health policy reforms 
 impacting pharmaceutical pricing in almost every major country in the EU.
 \n\nDELEGATE REGISTRATION:\n\nEmail - kavitha@virtueinsight.co.in or TEL:
  +44-20 3509 3779 \n\nPlease note that this is a PAID event and NOT A FRE
 E event (no complimentary passes available). Any invite\, email or ticket
 s issued mentioning it as a free pass or free ticket to this event throug
 h any third party site will strictly not be accepted by the organizer.\n\
 nEARLY BIRD PRICE (Valid Till 30th August 2021 - Not Valid for UK based a
 ttendees):\n\n1 Delegate @ £399 \n\n3 Delegates @ £999\n\nEARLY BIRD PRIC
 E (Valid Till 30th August 2021 – For UK based attendees):\n\n1 Delegate @
  £399+VAT\n\n3 Delegates @ £999+VAT\n\nSTANDARD PRICE (Valid From 31st Au
 gust 2021 - Not Valid for UK based attendees)\n\n1 Delegate @ £599\n\n3 D
 elegates @ £1299\n\nSTANDARD PRICE (Valid From 31st August 2021 - For UK 
 based attendees)\n\n1 Delegate @ £599+VAT\n\n3 Delegates @ £1299+VAT\n\nC
 onference Sponsor\, Exhibition Stall &amp\; Paid Speaker Slot - Please em
 ail your interest and queries to kavitha@virtueinsight.co.in &nbsp\;\n\nK
 EY SPEAKERS:\n\n\nBOXIONG TANG\, Executive Director\, Health Economics an
 d Outcomes Research (HEOR)\, BeiGene\nMARTIN ROST\, Senior Director\, Mar
 ket Access (Global)\, Pfizer\nJOLIE APICELLA\, Assistant\, U.S. Attorney’
 s Office\, EDNY\nYONGHUA JING \, Senior Director\, Health Economics and O
 utcomes Research\, Abbvie\nSHANTHY KRISHNARAJAH\, Executive Director\, Vi
 for Pharma\nGARY ELLEXSON\, VP Corporate Accounts\, Supernus Pharmaceutic
 als\nHEZEKIAH BLAKE\, Director - Portfolio Planning and Market Insights\,
  Ionis Pharmaceuticals\nRICHARD LINER \, Senior Assistant General Counsel
 \, Bayer\nANGELINA IRIZARI-POLICARPIO\, HEOR &amp\; Real World Evidence L
 eader of the U. S. Field Communications Team\, Eisai\nGREG APOSTOL\, Vice
  President &amp\; Head of Market Access\, Alkermes\nSAMUEL MURPHY \, CEO\
 , Salubris Biotherapeutics\nLAURENE REDDING\, Head\, Value\, Access &amp\
 ; Policy\, BeiGene\nMARTIJN NEGEN\, VP Commercial Strategy\, AM Pharma\nT
 IM HERMES\, VP Market Access\, Trade &amp\; Patient Services\, Aurinia Ph
 armaceuticals\nERIN MISTRY\, SVP\, Head of Payer Strategy\, Gov’t Affairs
  &amp\; Trade\, Cormedix\nALEXANDER NATZ\, Secretary General\, European C
 onfederation of Pharmaceutical Entrepreneurs (EUCOPE)\nMALLORY O’CONNOR\,
  Executive Director\, Public Policy\, Mallinckrodt Pharmaceuticals\nMICHA
 EL THOMPSON \, President &amp\; CEO\, National Alliance of Healthcare Pur
 chaser Coalitions\nROBERT POPOVIAN \, Chief Science Policy Officer\, Glob
 al Healthy Living Foundation &amp\; Senior Health Policy Fellow\, Progres
 sive Policy Institute\nELIZABETH JOHNSON\, CEO\, MedicoCX\nJOHN LINNELL\,
  State Captain\, COPD Foundation\nREED STEPHENS\, Partner\, Winston &amp\
 ; Strawn\n\nKEY THEMES:\n\n\nFormulating your best market access strategy
  during the pandemic\nUS policy challenges for market access: Stepping ah
 ead\, especially during this Covid19\nHow to capture and quantify patient
  value?\nUnrivalled opportunity to expose and address the market access c
 hallenges facing the industry\nThe role of Real World Evidence (RWE) in O
 ncology\nCurrent &amp\; future - Challenges &amp\; opportunities in pharm
 a pricing\, reimbursement &amp\; market access\nImproving patient and mar
 ket access through the development of targeted value propositions\, compr
 ehensive contract assessment\nMeasurement strategies through to in-depth 
 knowledge regarding payer formulary coverage trends\nHow can payers and i
 ndustry work together to ensure that innovative and valuable treatments m
 ake it to the market?\nUnderstanding - payers’ perspective\nAdvocating an
 d collaborating with payers for value in a new era\nCreating a robust pat
 ient services and reimbursement support program for biosimilar products\n
 Prioritising Patients! - Adding value through an innovative patient-cente
 red approach\nUnderstand how price affects market access and learn on how
  to set prices for optimal access and returns.\nNew drugs are failing to 
 gain reimbursement from payers/HTAs at an alarming rate\, despite being a
 pproved by regulators\nEvidence Generation - The strategic rigor and crea
 tivity applied to evidence generation\nImpact of social media and digital
  analytics\nDeveloping risk-sharing reimbursement models and value based 
 pricing\nPatient engagement and adherence within the environment\nExplain
 ing how to use the data sources and observational research for effective 
 safety analysis\nDwell ahead of regulatory developments &amp\; improving 
 your strategies in a cost effective way Accelerating new medicine introdu
 ction in developing world &amp\; overcoming challenges\nBe part of a majo
 r networking opportunity\n\nWHO SHOULD ATTEND:\n\nSenior Vice Presidents\
 , Vice Presidents\, Senior Executives\, Global Heads\, Heads\, Directors\
 , Senior Managers\, Managers of:\n\nPricing\, Reimbursement\, Market Acce
 ss\, Commercial Pricing\, Pricing Strategists\, Health Economics\, Outcom
 es Research\, Regulatory Affairs\, Governmental Affairs\, Public Affairs\
 , Public Policy Directors\, Operations\, Governmental bodies\, Regulatory
  bodies\n\nGet more from the event\, with a broader scope bringing the wh
 ole communications value chain together. Enjoy and make the best out of o
 ur dedicated networking time\, meet the leading international vendors sho
 wcasing the products of tomorrow in the virtual exhibition area. Expand y
 our knowledge of the latest business models and strategies in the high-le
 vel conference.\n
DTEND:20210929T170000
DTSTAMP:20260512T220830Z
DTSTART:20210928T090000
LOCATION:\,
SEQUENCE:0
SUMMARY:5th Pharma Pricing\, Reimbursement &amp\; Market Access 2021\n“Cri
 tical guide for successfully identifying your pricing\, reimbursement and
  market acc...
UID:6beb8bf5-32de-45c3-9b6b-c99b6c242df1
END:VEVENT
END:VCALENDAR